Loss of PTPN11/SHP2 in mice or in human metachondromatosis (MC) patients causes benign cartilage tumors on the bone surface (exostoses) and within bones (enchondromas). This evidence concerns the gene PTPN11 and benign chondrogenic neoplasm.